Posted on 4 月 18, 20224/18/22
FDA Moves Cybersecurity Into the Product Life Cycle
Posted on 4 月 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on 4 月 7, 20224/7/22
Reigniting Revenue for Established Brands
Posted on 4 月 7, 20224/7/22
Reignite Established Brands — Actual Use Case
Posted on 3 月 24, 20223/24/22
New Legislation Supports Payment for Digital Therapeutics
Posted on 3 月 23, 20223/23/22
How Do We Pay for a Cure? How to Put a Price on Life-changing Treatments
Posted on 3 月 22, 20223/22/22
Is Your Salesforce Keeping Up With Rapidly Evolving HCP Preferences?
Posted on 3 月 11, 20223/11/22
How Can Utilizing Digital Therapeutics Provide Better Care to the Veteran Population?
Posted on 3 月 10, 20223/10/22
Prescription Digital Therapeutics Coding: A Good First Step by CMS
Posted on 3 月 10, 20223/10/22